本页面由Tiger Trade Technology Pte. Ltd.提供服务

ADC Therapeutics SA

4.38
+0.01000.23%
盘后4.380.00000.00%19:33 EDT
成交量:220.64万
成交额:1,002.12万
市值:5.56亿
市盈率:-3.91
高:4.82
开:4.38
低:4.24
收:4.37
52周最高:4.98
52周最低:1.13
股本:1.27亿
流通股本:9,224.08万
量比:2.17
换手率:2.39%
股息:- -
股息率:- -
每股收益(TTM):-1.1200
每股收益(LYR):-1.1224
净资产收益率:-705.53%
总资产收益率:-20.56%
市净率:-2.99
市盈率(LYR):-3.90

数据加载中...

2023/03/21

SEC问询函

CORRESP [Cover] - Correspondence
2023/03/16

SEC问询函

Form CORRESP - Correspondence
2023/03/15

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/15

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/06

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/02

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/02/02

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2022/12/23

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/09

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/08

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/14

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/14

SEC问询函

CORRESP [Cover] - Correspondence
2022/06/30

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/17

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/08/03

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/05/06

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/04/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/18

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]